Nobuhiro Kado

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial

Masakazu Abé, Yasuyuki Hirashima, Yuka Kasamatsu et al. · Supportive Care in Cancer · 2015 · 68 citations

Cisplatin-based Chemotherapy, Medicine, Pharmacology +6

Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy

Munetaka Takekuma, Yuka Kasamatsu, Nobuhiro Kado et al. · International Journal of Clinical Oncology · 2016 · 40 citations

Gynecologic Surgery, Surgical Oncology, Cervical Cancer Management +13

Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients

Yasue Horiuchi, Hiroyuki Matsubayashi, Yoshimi Kiyozumi et al. · Human Genetics · 2020 · 25 citations

Sequencing, Exome Sequencing, Medicine +9

Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type

Hiroyuki Matsubayashi, Takuma Oishi, Keiko Sasaki et al. · Human Pathology · 2022 · 22 citations

Genome Instability, Somatic Variant, Tumor Heterogeneity +9

Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study

Hirotoshi Iihara, Mototsugu Shimokawa, Yoh Hayasaki et al. · Gynecologic Oncology · 2020 · 20 citations · Full text